Mathew Autterson is a leader in the business community of Colorado and a philanthropist who has used his business savvy to help people however he can. He has worked in the financial services industry for more than 25 years and has served in numerous executive and leadership roles during that time. Mathew attended Michigan State University and graduated from the college in 1980 after earning a Bachelor of Arts in Finance. He furthered his education by studying at the University of Denver Graduate Tax Program.
Mathew Autterson started out his working life by serving at First Trust Corporation. After staying with the company for a short period of time, he moved on to work with a subsidiary of Integrated Resources, Inc., which was a chartered trust located in Colorado. Eventually, Mathew decided to move on and work for Resources Trust Company, and in 1986 he was voted in as the president of the company. He stayed on with Resources Trust Company even after they were bought out by Broad Inc. and then SunAmerica as well as AIG.
A large part of the charitable work that Mathew Autterson does is through Falci Adaptive Biosystems (FAB) where he serves as a member of its Board of Directors. The nonprofit organization dedicates itself to improving the conditions of people who suffer from neuromotor disabilities so that they can live a free life where they are able to engage with the world around themselves. Mathew has also served in different leadership positions with the Board of the Denver Zoo as well as the Denver Zoological Foundation. He is also the Chairman of the Board of Directors of the Denver Hospice and serves with the Webb-Waring Foundation. See This Page for related information.
Mathew Autterson is active on social media, and if you look at his Twitter account, you will see a spread of tweets related to some of his personal interests, some of his favorite quotes, and quite a few related to the industry he works in. If you take a look at his Linkedin page, you will see that Mathew is also the Chief Executive Officer and President of CNS Biosciences, which is bioscience company in its clinical-stage and early-stage period that works to discover drugs that can help ease the neuropathic pain. He is also a member of the Board for the company that was started up by Scott Falci in 2013. You can also find a couple of articles on his Linkedin page featuring discoveries in medicine.